Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by Snowballgrowthon Sep 07, 2020 9:42pm
163 Views
Post# 31518723

RE:RE:RE:RE:RE:RE:Interesting Situation ...

RE:RE:RE:RE:RE:RE:Interesting Situation ...

drippingsnot wrote: I'm not too sure what the term "observer" really means so I assumed it wasn't an official title - otherwise you'd think they would have been called them board members.

Also it says we have "the right to" observers but we don't know the details of the agreement - could we get observers after a certain dollar amount is borrowed ?


Googled a definition ...

board observer is an individual who attends company board meetings but is not an official member of the Board of Directors. During a funding round some investors will request the right to appoint a board observer, this may or may not be set out in the investment terms.





 

For more the priorities should be optimisation, BD and buyback. I would be very surprised if J. Goodman / Knight don't buy below book value. That said they now need  more products to add value in the sales team hands. 

<< Previous
Bullboard Posts
Next >>